Unresectable Stomach Neoplasms
Showing 1 - 25 of 8,591
Stomach Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)
Completed
- Stomach Neoplasms
- Irreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Gastric Cancer Trial in Tianjin (AK104, Apatinib, Paclitaxel)
Recruiting
- Gastric Cancer
- AK104
- +3 more
-
Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
May 7, 2023
Immunotherapy in Conversion Therapy of Unresectable Gastric
Recruiting
- Unresectable Gastric Cancer
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Nov 8, 2022
Breast Cancer, Lung Cancer, Colorectal Cancer Trial in Kobe (e-PRO monitoring)
Enrolling by invitation
- Breast Cancer
- +7 more
- e-PRO monitoring
-
Kobe, Hyogo, JapanKobe University Graduate School
Jun 27, 2023
Gastric Cancer, Embolization Trial (Transarterial Chemoembolization)
Not yet recruiting
- Gastric Cancer
- Embolization
- Transarterial Chemoembolization
- (no location specified)
May 17, 2022
Gastric Cancer, Esophageal Cancer, Stomach Cancer Trial in Saint Louis (CA-4948, 5-FU, Leucovorin)
Not yet recruiting
- Gastric Cancer
- +4 more
- CA-4948
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 27, 2022
Safety and Efficacy of Trastuzumab BS
Not yet recruiting
- Gastric Cancer
- TRASTUZUMAB BS
- (no location specified)
Dec 19, 2022
Locally Advanced Unresectable Gastric Cancer Trial in Guangzhou (Pemigatinib)
Not yet recruiting
- Locally Advanced Unresectable Gastric Cancer
-
Guangzhou, Guangdong, ChinaCancer center of SunYat-sen University
Aug 11, 2023
Stomach Tumors, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Atezolizumab, Tiragolumab, Oxaliplatin)
Active, not recruiting
- Stomach Neoplasms
- +2 more
- Atezolizumab
- +3 more
-
Beijing, China
- +10 more
Dec 21, 2022
MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer Trial (S095029, Pembrolizumab 200 mg)
Not yet recruiting
- MSI-H/dMMR Gastroesophageal-junction Cancer
- MSI-H/dMMR Gastric Cancer
- S095029
- Pembrolizumab 200 mg
- (no location specified)
Oct 30, 2023
Gastric Cancer Trial (Disitamab Vedotin, Sintilimab, S-1)
Not yet recruiting
- Gastric Cancer
- Disitamab Vedotin
- +3 more
- (no location specified)
Nov 17, 2022
Gastric Cancer Trial in Seoul (Apatinib mesylate)
Completed
- Gastric Cancer
- Apatinib mesylate
-
Seoul, Songpa-gu, Korea, Republic ofAsan medical center
Jul 20, 2022
HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811, Ramucirumab / Paclitaxel/
Not yet recruiting
- HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
- SHR-A1811
- Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan
- (no location specified)
Nov 6, 2023
Gastric Carcinoma, Liver and Intrahepatic Bile Duct Carcinoma, Unresectable Esophageal Carcinoma Trial in Atlanta (Zinc)
Active, not recruiting
- Gastric Carcinoma
- +3 more
- Zinc
-
Atlanta, Georgia
- +1 more
Apr 1, 2022
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial
Not yet recruiting
- Advanced Esophageal Adenocarcinoma
- +14 more
- Fluorouracil
- +8 more
- (no location specified)
Jan 3, 2023
Stomach Tumor Trial in Seoul (Docetaxel injection, oxaliplatin, S-1)
Not yet recruiting
- Stomach Neoplasm
- Docetaxel injection, oxaliplatin, S-1
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jan 7, 2022
Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Nanoliposomal Irinotecan
- Trifluridine and Tipiracil Hydrochloride
-
Atlanta, Georgia
- +2 more
Jan 6, 2023
Gastric Cancer Trial in São Paulo (Gastro-entero anastomosis only, Gastric partitioning Plus Gastro-entero anastomosis)
Completed
- Gastric Cancer
- Gastro-entero anastomosis only
- Gastric partitioning Plus Gastro-entero anastomosis
-
São Paulo, BrazilInstituto do Câncer do Estado de São Paulo
Dec 17, 2021
Liver Metastases, Colorectal Cancer, Anal Canal Cancer Trial in São Paulo (SBRT)
Recruiting
- Liver Metastases
- +3 more
- SBRT
-
São Paulo, SP, BrazilInstituto do Cancer do Estado de São Paulo
Dec 15, 2021
Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High Trial in United States
Recruiting
- Advanced or Metastatic Solid Tumors
- +11 more
-
Tucson, Arizona
- +11 more
Dec 2, 2022
Liver Diseases, Liver Cancer, Liver Metastases Trial in Murcia (Liver Transplantation)
Not yet recruiting
- Liver Diseases
- +27 more
- Liver Transplantation
-
Murcia, SpainFelipe Alconchel
Feb 24, 2022
Gastric Cancer Trial in Zhengzhou (fruquintinib + sintilimab + SOX)
Not yet recruiting
- Gastric Cancer
- fruquintinib + sintilimab + SOX
-
Zhengzhou, Henan, China
- +1 more
Dec 15, 2021
Stomach Cancer, Gastric (Stomach) Cancer, Tumor of Cardioesophageal Junction Trial in Stanford (bevacizumab, carboplatin,
Completed
- Stomach Cancer
- +3 more
- bevacizumab
- +2 more
-
Stanford, CaliforniaStanford University School of Medicine
Jun 29, 2021
Gastric Cancer Stage Trial in Tianjin (sintilimab, apatinib, S1)
Recruiting
- Gastric Cancer Stage
- sintilimab
- +3 more
-
Tianjin, Tianjin, ChinaDepartment of Gastrointestinal Medical Oncology, Tianjin Medical
Jul 5, 2021